Basic information
Biomarker: chaperonin 10
Histology type: endometrial carcinoma
Cohort characteristics
Country: Canada
Region: Toronto
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 88 | EC | 44 | nonmalignant endometrial tissue | 44 |
Sample information
Conclusion: Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10.
Sample type : tissue
Sample method: SELDI-TOF MS /Western blot and immunohistochemistry
Expression pattern : increased expression
Expression elevation: The signal-to-noise (S/N) ratios of chaperonin 10 peaks were measured from highresolution spectra acquired on the QSTAR XL. (Applied Biosystems/MDS Sciex)The abundances from different samples were graded from “o” (complete absence) to “+++++” for S/N ≥ 10
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
